2022. Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?. Biomolecules and Biomedicine. 22, 4 (Jul. 2022), 660–664. DOI:https://doi.org/10.17305/bjbms.2021.6901.